Avalo Therapeutics, Inc. (AVTX)
16.86
+1.10
(+6.98%)
USD |
NASDAQ |
Jan 22, 10:47
Avalo Therapeutics EPS Diluted (Quarterly): -2.187 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | -0.4511 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.62M |
| Total Expenses (Quarterly) | 30.62M |
| Enterprise Value | 176.64M |
| Earnings Yield | -51.78% |
| Normalized Earnings Yield | -38.07 |